This is a firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The $4,145 contract is for a pre-clinical toxicology study of a drug developed for cancer patients, as part of the Toxicology of Drugs Developed for Cancer Patients contract vehicle. IITRI specializes in preclinical drug development services and has...
This is a $718,265.00 delivery order awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to IIT Research Institute, the research and technology development arm of Illinois Institute of Technology (IIT). The contract supports preclinical toxicology and pharmacology research for drugs developed for cancer patients, including exploratory studies of CCR4 CAR T cells. This work is performed under the NCI's "Toxicology of Drugs Developed for...
This is a delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to IIT Research Institute, a non-profit research organization, for a series of toxicology studies in rabbits for drugs developed for cancer patients. The $487,537.00 contract is part of the Toxicology of Drugs Developed for Cancer Patients indefinite delivery/indefinite quantity contract vehicle and includes dose range finding, preliminary embryo fetal...
The National Cancer Institute (NCI) awarded a $1,886,133.00 delivery order contract to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract is for toxicology studies in rats and dogs administered the compound AIT-102. The award is not associated with a set-aside designation. IITRI is a contract research organization that specializes in preclinical drug development services, including pharmacology, toxicology, safety, and efficacy...
This is a $631,772.00 delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for toxicology studies on reproductive effects in rats, supporting the NCCIH (National Center for Complementary and Integrative Health) program. This is a cost-plus-fixed-fee contract that was not set aside for any type of small...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $2,398.74 delivery order against the PREVENT Preclinical Drug Development Program indefinite-delivery/indefinite-quantity master contract to IIT Research Institute. IIT Research Institute, a subsidiary of the Illinois Institute Of Technology Sponsored Research And Programs Division, will provide a "CONTRACT ORIENTATION AND KICKOFF MEETING" as the prime contractor. The...
This is a federal contract award to IIT Research Institute by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The $2,111,543.00 firm fixed price delivery order is for support related to the aerosol development of the drug bexarotene under the PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) master indefinite delivery/indefinite quantity (IDIQ) contract. IIT Research Institute, the research and technology arm of Illinois...
This is a $1,010.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the IIT Research Institute (IITRI), a non-profit contract research organization. The contract is for a "Kick Off Meeting, Preclinical Pharmacokinetic & Pharmacology Evaluations of Agents Being Developed for Cancer Patients" with a performance period from July 1, 2016 to September 30, 2016. This work is being performed under NCI's Pharmacokinetic and Pharmacology Evaluations for...
This is a $9,353,817.00 Cost Plus Fixed Fee contract awarded to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology (IIT), by the National Cancer Institute (NCI) for preclinical toxicology services related to the development of cancer and other therapeutic large molecule drugs. The contract has no set-aside designation. IITRI is an experienced preclinical contract research organization that regularly supports the drug development efforts of federal...
This is a delivery order issued against the Preclinical Agent Development Assays 2012-2016 contract vehicle by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract was awarded to the IIT Research Institute (IITRI), a non-profit contract research organization, to conduct other functions related to preclinical in vitro and in vivo agent development assays, including an orientation meeting. The total ceiling value of this...